Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.8M Buy
33,608
+60
+0.2% +$21.4K 0.61% 34
2025
Q4
$11M Sell
33,548
-41
-0.1% -$13K 0.59% 37
2025
Q3
$9.48M Sell
33,589
-870
-3% -$252K 0.51% 45
2025
Q2
$9.62M Buy
34,459
+353
+1% +$100K 0.56% 43
2025
Q1
$10.6M Sell
34,106
-776
-2% -$229K 0.67% 34
2024
Q4
$9.09M Sell
34,882
-353
-1% -$105K 0.59% 39
2024
Q3
$11.4M Sell
35,235
-1,302
-4% -$426K 0.72% 34
2024
Q2
$11.4M Sell
36,537
-698
-2% -$205K 0.78% 26
2024
Q1
$10.6M Sell
37,235
-290
-0.8% -$84.9K 0.73% 36
2023
Q4
$10.8M Buy
37,525
+32
+0.1% +$8.72K 0.8% 23
2023
Q3
$10.1M Buy
37,493
+69
+0.2% +$17.2K 0.83% 23
2023
Q2
$8.31M Buy
37,424
+669
+2% +$155K 0.64% 29
2023
Q1
$8.89M Buy
36,755
+2,788
+8% +$684K 0.72% 25
2022
Q4
$8.92M Sell
33,967
-396
-1% -$106K 0.76% 25
2022
Q3
$7.75M Sell
34,363
-305
-0.9% -$73.9K 0.74% 29
2022
Q2
$8.44M Sell
34,668
-874
-2% -$214K 0.74% 30
2022
Q1
$8.6M Sell
35,542
-1,072
-3% -$246K 0.67% 34
2021
Q4
$8.24M Sell
36,614
-1,514
-4% -$320K 0.64% 40
2021
Q3
$8.11M Sell
38,128
-1,179
-3% -$271K 0.68% 38
2021
Q2
$9.58M Sell
39,307
-504
-1% -$124K 0.8% 30
2021
Q1
$9.9M Sell
39,811
-1,162
-3% -$277K 0.83% 25
2020
Q4
$9.42M Sell
40,973
-834
-2% -$192K 0.91% 24
2020
Q3
$10.6M Sell
41,807
-3,020
-7% -$748K 1.25% 17
2020
Q2
$10.6M Sell
44,827
-2,357
-5% -$538K 1.32% 14
2020
Q1
$9.57M Buy
47,184
+350
+0.7% +$76.4K 1.43% 15
2019
Q4
$11.3M Sell
46,834
-2,482
-5% -$547K 1.41% 15
2019
Q3
$9.54M Buy
49,316
+311
+0.6% +$59.7K 1.3% 16
2019
Q2
$9.03M Buy
49,005
+230
+0.5% +$41.2K 1.27% 19
2019
Q1
$9.27M Buy
48,775
+3,398
+7% +$649K 1.34% 18
2018
Q4
$8.83M Buy
45,377
+90
+0.2% +$17.6K 1.41% 16
2018
Q3
$9.39M Sell
45,287
-1,698
-4% -$335K 1.41% 19
2018
Q2
$8.67M Sell
46,985
-93
-0.2% -$16.4K 1.38% 20
2018
Q1
$8.03M Sell
47,078
-16
-0% -$2.94K 1.31% 21
2017
Q4
$8.19M Buy
47,094
+574
+1% +$102K 1.31% 22
2017
Q3
$8.67M Buy
46,520
+1,482
+3% +$263K 1.49% 17
2017
Q2
$7.76M Buy
45,038
+707
+2% +$115K 1.37% 22
2017
Q1
$7.27M Sell
44,331
-2,885
-6% -$479K 1.33% 25
2016
Q4
$6.9M Sell
47,216
-845
-2% -$127K 1.32% 26
2016
Q3
$8.02M Sell
48,061
-192
-0.4% -$32.5K 1.55% 16
2016
Q2
$7.34M Buy
48,253
+2,245
+5% +$349K 1.45% 22
2016
Q1
$6.9M Buy
46,008
+4,912
+12% +$730K 1.4% 21
2015
Q4
$6.67M Buy
41,096
+1,484
+4% +$233K 1.42% 22
2015
Q3
$5.47M Buy
39,612
+3,067
+8% +$483K 1.24% 27
2015
Q2
$5.61M Buy
36,545
+1,794
+5% +$287K 1.23% 27
2015
Q1
$5.55M Buy
34,751
+601
+2% +$94.7K 1.22% 28
2014
Q4
$5.44M Sell
34,150
-1,549
-4% -$241K 1.23% 28
2014
Q3
$5.01M Sell
35,699
-1,127
-3% -$147K 1.16% 32
2014
Q2
$4.36M Sell
36,826
-1,034
-3% -$120K 1.01% 36
2014
Q1
$4.67M Buy
37,860
+5,867
+18% +$712K 1.15% 33
2013
Q4
$3.65M Buy
31,993
+2,695
+9% +$307K 0.92% 42
2013
Q3
$3.28M Buy
29,298
+2,527
+9% +$274K 0.88% 49
2013
Q2
$2.64M Buy
+26,771
New +$2.78M 0.73% 55

Other funds holding AMGN

Foster & Motley's AMGN Position: Q1 2026 in Review

Foster & Motley increased its Amgen (AMGN) stake by 0.18% in Q1 2026, buying an estimated $21.4K and bringing the position to 33,608 shares worth $11.8M. The position accounts for 0.61% of the portfolio, ranked #34.

Foster & Motley first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Foster & Motley held 33,608 shares of Amgen worth $11.8M as of Q1 2026.
  • Foster & Motley bought 60 Amgen shares in Q1 2026, an estimated $21.4K.
  • Amgen made up 0.61% of Foster & Motley's portfolio in Q1 2026, its #34 holding.
  • Foster & Motley first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Foster & Motley's 13F filing for Q1 2026, filed 21 Apr 2026.